Back to 
U.S. Bancorp
U.S. Bancorp
KPTI
Showing 0 of 16 quarters
Position history for U.S. Bancorp's holdings in Karyopharm Therapeutics Inc.
No. U.S. Bancorp exited its KPTI (Karyopharm Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 3,989 shares worth $22,000. U.S. Bancorp already held KPTI in its Q1 2019 13F, the earliest on record, and held it in 15 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.